(2)The approval periods of the active substances mecoprop-p, propiconazole, propineb, propyzamide, pyraclostrobin and zoxamide were last extended by Commission Implementing Regulation (EU) 2016/2016note. The approval periods of those substances will expire on 31 January 2018.